COVID-19 Virtual Partnering event
COVID-19 Virtual Partnering is a unique and free-to-attend virtual event taking place on 20 April – 06 May
The initiative is backed by a consortium of biotech clusters and leading trade associations in the life sciences industry and represents a practical way to accelerate partnerships to develop and deliver solutions against COVID-19.
The event is open to all in the global life sciences industry to come together– the time is now to take partnering to the next level and help solve the COVID-19 crisis.
This online event is free of charge, but registration is necessary.
Inova, Lyonbiopole and Evaluate have joined forces to launch a unique virtual partnering event, backed by a consortium of biotech clusters and trade associations in the life sciences industry, to be held across the globe from 20 April to 6 May 2020. This initiative is supported by EIT Health.
Today’s COVID-19 crisis requires a previously unimaginable acceleration of output from the biopharmaceutical and life sciences industry. It raises the question about the ability to find the right partner in developing diagnostics, drug treatments and, ultimately, a COVID-19 vaccine. Beyond R&D – COVID-19 also raises a series of questions about the ability to handle the massive scale-up needed to deliver urgent solutions to protect health workers in the front line of the epidemic and patients alike.
The way forward requires an enormous leadership and collaboration effort within the life sciences industry to leave no stone unturned.
The answer? #PartneringAgainstCOVID19.
We are proud to announce that we are supporting a practical initiative that aims to accelerate partnerships within the life sciences industry and strengthen the response to this public health crisis. We encourage you to show your support by leveraging within your network and signing up.
From 20 April to 6 May 2020, a unique COVID-19 Virtual Partnering event will bring together small and big players to meet and match their skills and efforts.
Participation is open to any organization that provides product, knowledge, or technologies that can help in the effort to develop and produce testing, treatment and vaccine solutions to tackle the COVID-19 pandemic. Participants will be able to pursue:
Potential R&D collaborations
Tools for research projects
Drug repurposing
Partners for clinical trials
Biological markers and diagnostic tests for clinical trials
Animal and in-silico models
New suppliers for supply chain reinforcement
Funding and licensing
Production capabilities and scale-up know-how
Early stage discovery collaboration
Adjuvants, carrier systems, and formulation technologies
The event is supported by a consortium of biotech clusters and trade associations and represents a safe, structured and easy-to-use online meeting space for those working on solutions for COVID-19.
This initiative, proudly backed by LyonBiopole, Inova and Evaluate Ltd, will leverage Inova’s matchmaking platform that has been at the heart of major international biopharmaceutical conventions since 2015 and is by far the most efficient solution to connect companies at scale.
Follow the discussions on social media using #PartneringAgainstCOVID19 and #PartnerAtHome.
What is a virtual Partnering Event?
A partnering event usually aims to facilitate interactions between attendees at big conferences in convention centres. Instead, we’re providing a safe, structured and easy-to-use online space for those working on solutions for COVID-19.
· Meeting requests: Partnering meetings are unique in that the interactions are not serendipitous. Participants search for and request meetings with potential partners in our directory. Once accepted, they schedule the meeting via our online networking platform. Access to the directory and meeting scheduling will start from 20 April.
· Virtual meetings: Meetings take place from 4 May through 6 May using the online meeting system. Meetings only last 30 minutes. They are short but allow enough time for an introduction to the partner and their capabilities.
· Follow-ups: Although the initial meeting is short, the relationship continues afterwards.
What is the timeline?
How does this work?
· Each delegate enters a profile (organization, technology, product, expertise)
· Searchable directory of profiles
· Anyone can reach out to companies listed in the directory
· Meetings can be requested, accepted or declined
· Meetings are virtually organized and scheduled
· Each delegate has a personalized agenda of meetings